- Identification and Diagnosis
- High-risk patient populations
- Differential diagnosis
- Diagnostic testing
- Efficacy, Safety, Resistance Evidence
- Approved therapies
- Emerging agents
- Individualizing Treatment
- Guideline recommendations:
- Special populations
- Other considerations
- Patient/caregiver education
- Q & A session
Date / Time
Paul G. Auwaerter, MD, MBA
Sherrilyn and Ken Fisher Professor of Medicine
Divisions of Infectious Diseases and General Internal Medicine
Division of Infectious Diseases
Johns Hopkins School of Medicine
Michael G. Ison, MD, MS
Divisions of Infectious Diseases and Organ Transplantation
Northwestern University Feinberg School of Medicine
Tracy Zivin-Tutela, MD
Infectious Diseases Specialist of New Jersey
RWJ Barnabas Health and Saint Peter's University Hospital
New Brunswick, New Jersey
This goal of this webinar is to provide expert guidance and strategies for treating and managing influenza in high-risk populations.
Physicians, NPs, and PAs that specialize in caring for high-risk populations.
Upon completion of this activity, participants should be able to:
- Plan treatment strategies for flu treatment for adult patients at high risk for complications
- Summarize the available and emerging options for management of influenza in high-risk patients
- Individualize flu treatment for pediatric patients based on recent trial data and current recommendations
Joint Accreditation Statement
In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Designation of Credit
Practicing Clinicians Exchange designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit
Physician Assistant Continuing Medical Education
Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Conflicts of Interest
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose to the audience all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.